FVBF190115-0043


Bas Raaymakers (left), Professor, Experimental Clinical Physics at the University Medical Center Utrecht, in front of Elekta’s Atlantic system with Robert Spaninks, Elekta Service Engineer. Elekta plans to launch Atlantic in 2017, making radiation therapy much more precise, with the purpose of improving the lives of cancer patients.

Low resolution

Medium resolution

Original resolution

About Us

For almost five decades, Elekta has been a leader in precision radiation medicine. Our more than 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to – and benefits from – more precise, personalized radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visit elekta.com or follow @Elekta on Twitter.

Subscribe